Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL, 60637, USA.
Pfizer, San Diego, CA, 92121, USA.
Commun Biol. 2024 Jun 17;7(1):733. doi: 10.1038/s42003-024-06437-6.
Claudins are a 27-member family of ~25 kDa membrane proteins that integrate into tight junctions to form molecular barriers at the paracellular spaces between endothelial and epithelial cells. As the backbone of tight junction structure and function, claudins are attractive targets for modulating tissue permeability to deliver drugs or treat disease. However, structures of claudins are limited due to their small sizes and physicochemical properties-these traits also make therapy development a challenge. Here we report the development of a synthetic antibody fragment (sFab) that binds human claudin-4 and the determination of a high-resolution structure of it bound to claudin-4/enterotoxin complexes using cryogenic electron microscopy. Structural and biophysical results reveal this sFabs mechanism of select binding to human claudin-4 over other homologous claudins and establish the ability of sFabs to bind hard-to-target claudins to probe tight junction structure and function. The findings provide a framework for tight junction modulation by sFabs for tissue-selective therapies.
紧密连接蛋白是由 27 个成员组成的家族,分子量约为 25kDa 的膜蛋白,整合到紧密连接中,在内皮细胞和上皮细胞之间的细胞旁间隙形成分子屏障。作为紧密连接结构和功能的骨干,紧密连接蛋白是调节组织通透性以递送药物或治疗疾病的有吸引力的靶标。然而,由于其小尺寸和物理化学性质,紧密连接蛋白的结构受到限制——这些特征也使得治疗开发成为一个挑战。在这里,我们报告了一种与人紧密连接蛋白-4 结合的合成抗体片段 (sFab) 的开发,并使用低温电子显微镜确定了它与紧密连接蛋白-4/肠毒素复合物结合的高分辨率结构。结构和生物物理结果揭示了这种 sFab 选择性结合人紧密连接蛋白-4 而不是其他同源紧密连接蛋白的机制,并确立了 sFab 结合难以靶向的紧密连接蛋白以探测紧密连接结构和功能的能力。这些发现为 sFab 通过紧密连接调节提供了一个组织选择性治疗的框架。